Press area

Press area

Cafeine to prevent Alzheimer disease? CAFCA clinical trial at the Lille University Hospital

Cafeine to prevent Alzheimer disease? The Dr Thibaud Lebouvier, neurologist at the Memory Center of the  Lille University Hospital has received a grant to conduct the CAFCA clinical trial. This clinical trial aims to measure the capacity of coffee (more precisely cafeine) to slow down/prevent the symptoms of Alzheimer disease. This project is in collaboration … Continue reading “Cafeine to prevent Alzheimer disease? CAFCA clinical trial at the Lille University Hospital”

AGENDA

  1. LiCEND Summer school 2019 : Experimental Models for Neurodegenerative Disease: From Cells to Model Organisms

    2 July / 5 July

NEWS

SCIENTIFIC PRODUCTION